Pre-market hot trades in US stocks: Flex up 3.02% in pre-market; ON Semiconductor up 3.01% in pre-market

Pre-market Hot Trades in US Stocks

Flex rose 3.02% in pre-market trading. Based on recent news,

1. On July 17, MarketBeat reported that Flex currently has a moderate buy rating among analysts. Nevertheless, top analysts believe there are five stocks that are more worthy of purchase than Flex. This news may have positively impacted investor confidence, driving the stock price up.

2. On July 20, Simply Wall St released a new AI stock screener to help investors discover market opportunities. Although Flex was not specifically mentioned, the overall improvement in market sentiment may have indirectly driven the stock's rise. Improved market sentiment has pushed the stock price up.

ON Semiconductor rose 3.01% in pre-market trading. Based on recent key news:

1. On July 19, AI cloud data center operators are heavily investing in building AI data centers, promoting semiconductor companies like ON Semiconductor to vertically integrate their manufacturing models to meet AI demand. This move has enhanced market expectations for ON Semiconductor, leading to a rise in stock price. Source: Xian Tan Investment Weekly

2. On July 17, ON Semiconductor acquired Synaptics to enhance its competitiveness in the AI inference market. This strategic move attracted investor attention, driving the stock price up. Source: Getty Images

3. On July 17, with the surge in demand for AI infrastructure, ON Semiconductor prioritized fulfilling high-profit AI orders with its own wafer capacity, stabilizing delivery times and boosting market confidence. Source: Xian Tan Investment Weekly AI demand drives growth in the semiconductor industry.

Top Gainers in Pre-market US Stocks

Baiya rose 72.46% in pre-market trading. Based on recent news,

1. On July 17, GrowHub announced a $400 million merger agreement with EnChem, causing the stock price to surge by 86%. This news boosted market confidence in the related industry, driving Baiya's stock price up.

2. On July 17, Netflix released its second-quarter earnings report, which was mixed, and provided a weak third-quarter guidance, causing its stock price to drop by 9.6%. This news raised concerns in the market regarding tech stocks, indirectly affecting Baiya's stock price volatility.

3. On July 17, Jasper Therapeutics announced a merger with Kira Pharmaceuticals, leading to a 13.4% drop in its stock price. This news negatively impacted the biotech sector, further exacerbating market volatility. The market reacted strongly to the merger and earnings report news, increasing volatility.

Sadot rose 37.35% in pre-market trading. Based on recent key news:

1. On July 17, Sadot reached a settlement agreement with Helena Global Investment, ending legal disputes and terminating a $10 million equity credit line. This move pushed the stock price up by over 41%. Source: EDGAR

2. On July 14, Sadot completed the acquisition of TradeIQ software assets for $6 million, aiming to improve its capital structure and restore compliance with Nasdaq's minimum shareholder equity requirements. Source: EDGAR

3. On July 16, Sadot launched a financing of up to $100 million in senior secured convertible notes to enhance liquidity and support growth plans. Source: SEC filings, with increased volatility in the commodities and agricultural trading sectors.

Advanced Biomed pre-market rose 22.66%. Based on recent news,

1. On July 17, Advanced Biomed filed documents with the SEC announcing the termination of its purchase agreement with Helena Global Investment Opportunities I Ltd. The termination of this agreement will take effect on July 21, 2026. This news may have triggered positive market expectations regarding the company's future capital operations, driving the stock price up.

2. On July 17, Advanced Biomed released an 8-K filing detailing the relevant matters regarding the termination of the purchase agreement. Investors may view this decision as beneficial for the company to better manage its capital structure, thereby boosting market confidence.

3. Recently, Advanced Biomed's technical sentiment signals indicated a sell, but the market reacted positively to the company's termination of the purchase agreement, resulting in a significant rise in stock price. The biopharmaceutical industry has been active recently, attracting high investor attention